PMDA's Vision for Horizon Scanning of Emerging Technologies Potentially Relevant to the Development of New Medical Products: The Regulatory Challenge

Clin Pharmacol Ther. 2021 Feb;109(2):295-298. doi: 10.1002/cpt.1986. Epub 2020 Aug 18.

Abstract

A key goal of regulatory agencies for medical products is to make innovative products available to patients and the medical community in a timely manner in order to improve the quality of public health and health care. Thus, regulators must respond quickly to emerging technologies. It is a horizon scanning method, based on which the Japanese regulatory agency will have the expertise prior to review of forthcoming products of evolving technologies.

MeSH terms

  • Delivery of Health Care / legislation & jurisprudence
  • Drug Approval / legislation & jurisprudence
  • Drug Development / legislation & jurisprudence*
  • Government Agencies / legislation & jurisprudence
  • Humans
  • Japan